Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
Authors: Catherine De Angelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marusic, A. John P.M. Overbeke, Torben V. Schroeder, Harold C. Sox, Martin B. Van Der Weyden
Journal: Annals of Internal Medicine (2004)

Editorials21 September 2004Clinical Trial Registration: A Statement from the International Committee of Medical Journal EditorsFREECatherine De Angelis, MD, MPH, Jeffrey M. Drazen, MD, Frank A. Frizelle, MBChB, MMedSc, FRACS, Charlotte Haug, MD, PhD, MSc, John Hoey, MD, Richard Horton, FRCP, Sheldon Kotzin, MLS, Christine Laine, MD, MPH, Ana Marusic, MD, PhD, A. John P.M. Overbeke, MD, PhD, Torben V. Schroeder, MD, DMSc, Harold C. Sox, MD, and Martin B. Van Der Weyden, MDCatherine De Angelis, MD, MPH, Jeffrey M. Drazen, MD, Frank A. Frizelle, MBChB, MMedSc, FRACS, Charlotte Haug, MD, PhD, MSc, John Hoey, MD, Richard Horton, FRCP, Sheldon Kotzin, MLS, Christine Laine, MD, MPH, Ana Marusic, MD, PhD, A. John P.M. Overbeke, MD, PhD, Torben V. Schroeder, MD, DMSc, Harold C. Sox, MD, and Martin B. Van Der Weyden, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-141-6-200409210-00109 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Altruism and trust lie at the heart of research on human subjects. Altruistic individuals volunteer for research because they trust that their participation will contribute to improved health for others and that researchers will minimize risks to participants. In return for the altruism and trust that make clinical research possible, the research enterprise has an obligation to conduct research ethically and to report it honestly. Honest reporting begins with revealing the existence of all clinical studies, even those that reflect unfavorably on a research sponsor's product.Unfortunately, selective reporting of trials does occur, and it distorts the body of evidence available for clinical decision making. Researchers (and journal editors) are generally most enthusiastic about the publication of trials that show either a large effect of a new treatment (positive trials) or equivalence of two approaches to treatment (noninferiority trials). Researchers (and journals) typically are less excited about trials that show that a new treatment is inferior to standard treatment (negative trials) and even less interested in trials that are neither clearly positive nor clearly negative, since inconclusive trials will not in themselves change practice. Irrespective of their scientific interest, trial results that place financial interests at risk are particularly likely to remain unpublished and hidden from public view. The interests of the sponsor or authors notwithstanding, anyone should be able to learn of any trial's existence and its important characteristics.The case against selective reporting is particularly compelling for research that tests interventions that could enter mainstream clinical practice. Rather than a single trial, it is usually a body of evidence, consisting of many studies, that changes medical practice. When research sponsors or investigators conceal the presence of selected trials, these studies cannot influence the thinking of patients, clinicians, other researchers, and experts who write practice guidelines or decide on insurance-coverage policy. If all trials are registered in a public repository at their inception, every trial's existence is part of the public record and the many stakeholders in clinical research can explore the full range of clinical evidence. We are far from this ideal at present, since trial registration is largely voluntary, registry data sets and public access to them vary, and registries contain only a small proportion of trials. In this editorial, published simultaneously in all member journals, the International Committee of Medical Journal Editors (ICMJE) proposes comprehensive trials registration as a solution to the problem of selective awareness and announces that all 11 ICMJE member journals will adopt a trials-registration policy to promote this goal.The ICMJE member journals will require, as a condition of consideration for publication, registration in a public trials registry. Trials must register at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after July 1, 2005. For trials that began enrollment prior to this date, the ICMJE member journals will require registration by September 13, 2005, before considering the trial for publication. We speak only for ourselves, but we encourage editors of other biomedical journals to adopt similar policies. For this purpose, the ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (for example, phase I trials), would be exempt.The ICMJE does not advocate one particular registry, but its member journals will require authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include at minimum the following information: a unique identifying number, a statement of the intervention (or interventions) and comparison (or comparisons) studied, a statement of the study hypothesis, definitions of the primary and secondary outcome measures, eligibility criteria, key trial dates (registration date, anticipated or actual start date, anticipated or actual date of last follow-up, planned or actual date of closure to data entry, and date trial data considered complete), target number of subjects, funding source, and contact information for the principal investigator. To our knowledge, at present, only www.clinicaltrials.gov, sponsored by the United States National Library of Medicine, meets these requirements; there may be other registries, now or in the future, that meet all these requirements.Registration is only part of the means to an end; that end is full transparency with respect to performance and reporting of clinical trials. Research sponsors may argue that public registration of clinical trials will result in unnecessary bureaucratic delays and destroy their competitive edge by allowing competitors full access to their research plans. We argue that enhanced public confidence in the research enterprise will compensate for the costs of full disclosure. Patients who volunteer to participate in clinical trials deserve to know that their contribution to improving human health will be available to inform health care decisions. The knowledge made possible by their collective altruism must be accessible to everyone. Required trial registration will advance this goal.Catherine De Angelis, MD, MPH, Editor-in-Chief, Journal of the American Medical AssociationJeffrey M. Drazen, MD, Editor-in-Chief, The New England Journal of MedicineProfessor Frank A. Frizelle, MBChB, MMedSc, FRACS, Editor, The New Zealand Medical JournalCharlotte Haug, MD, PhD, MSc, Editor-in-Chief, Norwegian Medical JournalJohn Hoey, MD, Editor, Canadian Medical Association JournalRichard Horton, FRCP, Editor, The LancetSheldon Kotzin, MLS, Executive Editor, MEDLINE; National Library of MedicineChristine Laine, MD, MPH, Senior Deputy Editor, Annals of Internal MedicineAna Marusic, MD, PhD, Editor, Croatian Medical JournalA. John P.M. Overbeke, MD, PhD, Executive Editor, Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine)Torben V. Schroeder, MD, DMSc, Editor, Journal of the Danish Medical AssociationHarold C. Sox, MD, Editor, Annals of Internal MedicineMartin B. Van Der Weyden, MD, Editor, The Medical Journal of AustraliaCatherine De Angelis, MD, MPHEditor-in-Chief, Journal of the American Medical AssociationJeffrey M. Drazen, MDEditor-in-Chief, The New England Journal of MedicineProfessor Frank A. Frizelle, MBChB, MMedSc, FRACSEditor, The New Zealand Medical JournalCharlotte Haug, MD, PhD, MScEditor-in-Chief, Norwegian Medical JournalJohn Hoey, MDEditor, Canadian Medical Association JournalRichard Horton, FRCPEditor, The LancetSheldon Kotzin, MLSExecutive Editor, MEDLINE; National Library of MedicineChristine Laine, MD, MPHSenior Deputy Editor, Annals of Internal MedicineAna Marusic, MD, PhDEditor, Croatian Medical JournalA. John P.M. Overbeke, MD, PhDFrom Executive Editor, Nederlands Tijdschrift voor Geneeskunde.Torben V. Schroeder, MD, DMScEditor, Journal of the Danish Medical AssociationHarold C. Sox, MDEditor, Annals of Internal MedicineMartin B. Van Der Weyden, MDEditor, The Medical Journal of Australia Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Catherine De Angelis, MD, MPH; Jeffrey M. Drazen, MD; Frank A. Frizelle, MBChB, MMedSc, FRACS; Charlotte Haug, MD, PhD, MSc; John Hoey, MD; Richard Horton, FRCP; Sheldon Kotzin, MLS; Christine Laine, MD, MPH; Ana Marusic, MD, PhD; A. John P.M. Overbeke, MD, PhD; Torben V. Schroeder, MD, DMSc; Harold C. Sox, MD; Martin B. Van Der Weyden, MDAffiliations: Corresponding Author: Customer Service, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRegistration of Clinical Trials Alain Braillon , Gérard Dubois , and Michel Slama Registration of Clinical Trials Christine Laine and Harold C. Sox International Committee of Medical Journal Editors' Definition of a Clinical Trial Christine Laine Metrics Cited byHas the degree of outcome reporting bias in surgical randomized trials changed? A meta‐regression analysisReporting and transparent research practices in sports medicine and orthopaedic clinical trials: a meta-research studyClinical trial registration was associated with lower risk of bias compared with non-registered trials among trials included in systematic reviewsStrategies for using topical corticosteroids in children and adults with eczemaProspective trial registration and publication rates of randomized clinical trials in digital health: A cross-sectional analysis of global trial registriesReferencesClinical trial registry searches are under-utilized in systematic reviews from critical care journals: A bibliometric analysisSelective outcome reporting in root coverage randomized clinical trialsPatient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug AdministrationUse of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysisPoor compliance of clinical trial registration among trials included in systematic reviews: a cohort studyPublication Rate and Consistency of Registered Trials of Motor-Based Stroke RehabilitationRegistering your research: What's required?Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately ApprovedCharacteristics of studies of pharmacist services registered in ClinicalTrials.govFrom registration to publication: A study on Dutch academic randomized controlled trialsEthical and Policy Issues for Seamless Phase I Oncology TrialsForensic science needs registered reportsComparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and PublicationDialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysisAmerican College of Physicians Ethics Manual Seventh EditionLois Snyder Sulmasy, JD and Thomas A. Bledsoe, MD, for the ACP Ethics, Professionalism and Human Rights Committee*A Risk-Based Paradigm of Biomarkers in Clinical TrialsInteresting TimesThe enforcement of mandatory disclosure rulesAn observational analysis of discontinuation and non-publication of osteoarthritis trialsDifferences between protocols for randomized controlled trials and systematic reviewsA mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non–high-income regionsPublication of Randomized Clinical Trials in Pediatric ResearchOpen season: positive changes for increased transparency in the biomedical literatureKeeping a watchful eye on the food giants and cleansing the temple of nutritional medicine and epidemiologyThe Role and Importance of Clinical Trial Registries and Results DatabasesClinical trial registry use in anaesthesiology systematic reviewsData Escrow and Clinical Trial TransparencyHarlan M. Krumholz, MD, SM and Jeanie Kim, JDPublication Rates of Abstracts Presented at the Society of General Internal Medicine Annual MeetingPhase-II trials in osteosarcoma recurrences: A systematic review of past experienceOn Fishing for Significance and Statistician's Degree of Freedom in the Era of Big Molecular DataThe method of systematic review for clinical guidelinesA metadata schema for data objects in clinical researchRandomized trials in top dermatological journals, 2009-13Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reportingApplication of an automated natural language processing (NLP) workflow to enable federated search of external biomedical content in drug discovery and developmentCONSORT and clinical trial reporting: room for improvementDeveloping timely insights into comparative effectiveness research with a text-mining pipelineThe Changing Geography of Clinical Research: A Critical Analysis of Its DriversManaging the incidence of selective reporting bias: a survey of Cochrane review groupsConsiderations from the risk of bias perspective for updating Cochrane reviewsRegistration status and outcome reporting of trials published in core headache medicine journalsPeer reviewDo surgery journals insist on reporting by CONSORT and PRISMA? A follow-up survey of 'instructions to authors'Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological studyStandardization of Patient Outcomes Reporting in Percutaneous NephrolithotomyDesign and execution of clinical trials in orthopaedic surgeryMaking Prospective Registration of Observational Research a RealityReplication and the Manufacture of Scientific Inferences: A Formal ApproachElectromagnetic fields for treating osteoarthritisHow Psychiatry Journals Support the Unbiased Translation of Clinical Research. A Cross-Sectional Study of Editorial PoliciesIntegrated disease management interventions for patients with chronic obstructive pulmonary diseaseEuropean Union Clinical Trials Register: on the way to more transparency of clinical trial dataPRAISE (Prospective Randomized Amlodipine Survival Evaluation) and Criticism ∗What If We Were Texas Sharpshooters? Predictor Reporting Bias in Regression AnalysisLearning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical dataOpen-access clinical trial registries: the Italian scenarioPublishing Results of Clinical Trials and Reviewing Papers for PublicationTrial registration in Latin America and the Caribbean's: study of randomized trials published in 2010Normative arguments and new solutions for the unbiased registration and publication of clinical trialsThe Growth of Clinical Trials and Systematic Reviews in Informing Dermatological Patient CareAmerican College of Physicians Ethics Manual Sixth EditionLois Snyder, JD, for the American College of Physicians Ethics, Professionalism, and Human Rights Committee*The Role and Importance of Clinical Trial Registries and Results DatabasesRegistration and Reporting Guidelines for Clinical TrialsDisclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research TransparencyWalking the talk: the need for a trial registry for development interventionsLimited accessibility to designs and results of Japanese large-scale clinical trials for cardiovascular diseasesIntegrated disease management interventions for patients with chronic obstructive pulmonary diseaseRegistration of epidemiological studies: benefits and risksWorldwide Clinical Interventional Studies on Leading Causes of Death: A Descriptive AnalysisWorldwide Behavioral Research on Major Global Causes of MortalityZur Ethik einer restriktiven Regulierung der StudienregistrierungReporting of noninferiority trials was incomplete in trial registriesEarly phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysisBest Practice in Systematic Reviews: The Importance of Protocols and RegistrationBotulinum toxin injection for tennis elbowObstacles to researching the researchers: A case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trialsInfluence of trial registration on reporting quality of randomized trials: Study from highest ranked journalsRCT of urethral versus suprapubic catheterizationCONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized TrialsKenneth F. Schulz, PhD, MBA, Douglas G. Altman, DSc, and David Moher, PhD, for the CONSORT Group*Implementing registries and results databases of clinical trials: is there a side effect?Can Clinical Trial Results Databases and Manuscripts Coexist?ReferencesClinical Trial Overview and Enrollment«Conflict of Interest» oder Interesse am Konflikt? Vom Umgang mit Erkenntnis und Interesse in der MedizinPrimary registry of the WHO International Clinical Trial Registry Platform: Clinical Research Information Service (CRIS)Missing a critical piece of the pie: simple document search strategies inadequate for systematic reviewsTrials, tricks and transparency: How disclosure rules affect clinical knowledgeJournal of Foot and Ankle Research, one year onOutcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label UseBidirectional Conflicts of Interest Involving Industry and Medical Journals: Who Will Champion Integrity?The Role of Conflict of Interest in Reporting of Scientific InformationPharmaceutical Product Liabilities: A Review of Current Status and Future TrendsSubmission of clinical studies to ethics committees or clinical trials registers: the authors' point of viewAssessment of registration quality of trials sponsored by ChinaGuidelines, Consensus Conferences and Overviews (Meta-analysis)Developing a Research GroupThe Use of Electronic Data Capture Tools in Clinical Trials: Web-Survey of 259 Canadian TrialsWar, enmity, and statistical tablesEndorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'War, Enmity, and Statistical TablesPoor Reporting of Scientific Leadership Information in Clinical Trial RegistersDo we learn the right things from clinical trials?A perspective on risks that impede development of drugs to modify the course of Alzheimer's disease: Can they be reduced?Do trialists endorse clinical trial registration? Survey of a Pubmed sampleReview of new regulations for the conduct of clinical trials of investigational medicinal productsRegistro dos ensaios clínicosPaliperidone: quo vadis?Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial designPeer review policies and theCanadian Journal of Anesthesia: an update for authors and readersReported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000–2005Clinical research design and reporting: always room for improvement!Quality assessment of randomized controlled trials in the treatment of hepatocellular carcinomaNew regulatory rules for clinical trials in the United States and the European Union: Key points and comparisonsThe Editor as umpire: clinical trial registration and dispute resolutionQuality of Trials in a Systematic Review of Powered Toothbrushes: Suggestions for Future Clinical TrialsThe need to register clinical trials in orthodonticsClinical trial data: to disclose or not to disclose?International Committee of Medical Journal Editors' Definition of a Clinical TrialChristine Laine, MD, MPH, Senior Deputy EditorIs This Clinical Trial Fully Registered? A Statement from the International Committee of Medical Journal Editors*Catherine D. De Angelis, MD, MPH, Jeffrey M. Drazen, MD, Frank A. Frizelle, MB, ChB, MMedSc, FRACS, Charlotte Haug, MD, PhD, MSc, John Hoey, MD, Richard Horton, FRCP, Sheldon Kotzin, MLS, Christine Laine, MD, MPH, Ana Marusic, MD, PhD, A. John P.M. Overbeke, MD, PhD, Torben V. Schroeder, MD, DMSc, Harold C. Sox, MD, and Martin B. Van Der Weyden, MDAnnals 2004–2005: A Peek Back and a Look ForwardThe EditorsRegistration of Clinical TrialsAlain Braillon, MD, Gérard Dubois, MD, and Michel Slama, MDRegistro (de ensayos clínicos) sin fronteras 21 September 2004Volume 141, Issue 6Page: 477-478KeywordsClinical trial reportingClinical trialsHealth careHeartInformation storage and retrievalLibrariesPharmacokineticsResearch ethicsToxicityTreatment guidelines ePublished: 21 September 2004 Issue Published: 21 September 2004 PDF downloadLoading ...